HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Masanori Hara Selected Research

podocalyxin

5/2015A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
9/2012Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
6/2012Severe intraglomerular detachment of podocytes in a Gitelman syndrome patient.
2/2005Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Masanori Hara Research Topics

Disease

2Wilms Tumor (Wilm's Tumor)
05/2015 - 06/2012
2Acute Kidney Injury (Acute Renal Failure)
04/2011 - 09/2010
2Pathologic Constriction (Stenosis)
10/2010 - 02/2009
2Proteinuria
01/2005 - 01/2003
1Fibrosis (Cirrhosis)
06/2015
1Atrophy
06/2015
1Fabry Disease (Fabry's Disease)
05/2015
1Ischemia
01/2014
1Abdominal Aortic Aneurysm
01/2014
1Aneurysm (Aneurysms)
01/2014
1Myocardial Infarction
01/2013
1IGA Glomerulonephritis (IGA Nephropathy)
09/2012
1Sclerosis
09/2012
1Acute Coronary Syndrome
10/2010
1Infection
08/2010
1Fistula
08/2010
1False Aneurysm (Pseudoaneurysm)
08/2010
1Cardiomyopathies (Cardiomyopathy)
12/2006
1Nephritis
02/2005
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2005
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
01/2005
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2005
1Glomerulonephritis
01/2003

Drug/Important Bio-Agent (IBA)

4podocalyxinIBA
05/2015 - 02/2005
2VimentinIBA
05/2015 - 06/2012
1CollagenIBA
06/2015
1globotriaosylceramide (globotriosylceramide)IBA
05/2015
1AntibodiesIBA
05/2015
1GalactosidasesIBA
05/2015
1salicylhydroxamic acid (SHAM)IBA
01/2013
1CreatinineIBA
09/2012
1nephrinIBA
06/2012
1Biological Markers (Surrogate Marker)IBA
04/2011
1Creatine Kinase (Creatine Phosphokinase)IBA
12/2006
1Lipoproteins (Lipoprotein)IBA
01/2005
1Polymyxin B (Aerosporin)FDA LinkGeneric
01/2003

Therapy/Procedure

4Transplants (Transplant)
01/2014 - 02/2009
2Transplantation (Transplant Recipients)
06/2015 - 01/2014
1Homologous Transplantation (Allograft)
06/2015
1Thoracotomy
10/2010
1Peritoneal Dialysis
09/2010
1Debridement
08/2010
1Assisted Circulation
08/2010
1Induced Heart Arrest (Cardioplegia)
12/2006
1Blood Component Removal (Apheresis)
01/2005
1Hemoperfusion
01/2003